Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor

YX Pan, J Cheng, J Xu, G Rossi, E Jacobson, J Ryan-Moro, AI Brooks, GE Dean, KM Standifer and GW Pasternak

Cotzias Laboratory of Neuro-Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

We have identified a putative opioid receptor from mouse brain (KOR-3), belonging to the G protein-coupled receptor family, that is distinct from the previously cloned mu, delta, and kappa 1 receptors. Assignment of the clone to the opioid receptor family derives from both structural and functional studies. Its predicted amino acid sequence is highly homologous to that of the other opioid receptors, particularly in many of the transmembrane regions, where long stretches are identical to mu, delta, and kappa 1 receptors. Both cyclazocine and nalorphine inhibit cAMP accumulation in COS-7 cells stably expressing the clone. Northern analysis shows that the mRNA is present in brain but not in a number of other organs. Southern analysis suggests a single gene encoding the receptor. A highly selective monoclonal antibody directed against the native kappa 3 receptor recognizes, in Western analysis, the clone expressed in COS-7 cells. The in vitro translation product is also labeled by the antibody. Additional clones reveal the presence of several introns, including one in the second extracellular loop and another in the first transmembrane region. Antisense studies with an oligodeoxynucleotide directed against a region of the second extracellular loop reveal a selective blockade of kappa 3 analgesia in vivo that is not observed with a mismatch oligodeoxynucleotide based upon the antisense sequence. The mu, delta, and kappa 1 analgesia is unaffected by this antisense treatment. Antisense mapping of the clone downstream from the splice site in the first transmembrane region reveals that six different antisense oligodeoxynucleotides all block kappa 3 analgesia. In contrast, only one of an additional six different antisense oligodeoxynucleotides directed at regions upstream from this splice site is effective. This strong demarcation between the two regions raises the possibility of splice variants of the receptor. An additional clone reveals an insert in the 3' untranslated region. In conclusion, the antibody and antisense studies strongly associate KOR-3 with the kappa 3-opioid receptor, although it is not clear whether it is the kappa 3 receptor itself or a splice variant.

Volume 47, Issue 6, pp. 1180-1188, 06/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				G. Bregola, S. Zucchini, D. Rodi, A. Binaschi, C. D'Addario, D. Landuzzi, R. Reinscheid, S. Candeletti, P. Romualdi, and M. Simonato Involvement of the Neuropeptide Nociceptin/Orphanin FQ in Kainate Seizures J. Neurosci., November 15, 2002; 22(22): 10030 - 10038. [Abstract] [Full Text] [PDF]

				Y.-X. Pan, J. Xu, L. Mahurter, E. Bolan, M. Xu, and G. W. Pasternak Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene PNAS, November 20, 2001; 98(24): 14084 - 14089. [Abstract] [Full Text] [PDF]

				J. S. Mogil and G. W. Pasternak The Molecular and Behavioral Pharmacology of the Orphanin FQ/Nociceptin Peptide and Receptor Family Pharmacol. Rev., September 1, 2001; 53(3): 381 - 415. [Abstract] [Full Text] [PDF]

				D. R. Kapusta, J.-K. Chang, and V. A. Kenigs Central Administration of [Phe1Psi (CH2-NH)Gly2]Nociceptin(1-13)-NH2 and Orphanin FQ/Nociceptin (OFQ/N) Produce Similar Cardiovascular and Renal Responses in Conscious Rats J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 173 - 180. [Abstract] [Full Text]

				L. Leventhal, R. M. Silva, G. C. Rossi, G. W. Pasternak, and R. J. Bodnar Morphine-6beta -Glucuronide-Induced Hyperphagia: Characterization of Opioid Action By Selective Antagonists and Antisense Mapping in Rats J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 538 - 544. [Abstract] [Full Text]

				P. A. Zaki and C. J. Evans {blacksquare} REVIEW : ORL-1: An Awkward Child of the Opioid Receptor Family Neuroscientist, May 1, 1998; 4(3): 172 - 184. [Abstract] [PDF]

				M.-C. Ko, E. R. Butelman, J. R. Traynor, and J. H. Woods Differentiation of Kappa Opioid Agonist-Induced Antinociception by Naltrexone Apparent pA2 Analysis in Rhesus Monkeys, J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 518 - 526. [Abstract] [Full Text]

				F. Meng, Y. Ueda, M. T. Hoversten, L. P. Taylor, R. K. Reinscheid, F. J. Monsma, S. J. Watson, O. Civelli, and H. Akil Creating a Functional Opioid Alkaloid Binding Site in the Orphanin FQ Receptor through Site-Directed Mutagenesis Mol. Pharmacol., April 1, 1998; 53(4): 772 - 777. [Abstract] [Full Text]

				Y. Kolesnikov, S. Jain, R. Wilson, and G. W. Pasternak Lack of Morphine and Enkephalin Tolerance in 129/SvEv Mice: Evidence for a NMDA Receptor Defect J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 455 - 459. [Abstract] [Full Text]

				J. K. Staley, R. B. Rothman, K. C. Rice, J. Partilla, and D. C. Mash kappa 2 Opioid Receptors in Limbic Areas of the Human Brain Are Upregulated by Cocaine in Fatal Overdose Victims J. Neurosci., November 1, 1997; 17(21): 8225 - 8233. [Abstract] [Full Text] [PDF]

				G. P. Brown, K. Yang, O. Ouerfelli, K. M. Standifer, D. Byrd, and G. W. Pasternak 3H-Morphine-6beta -Glucuronide Binding in Brain Membranes and an MOR-1-Transfected Cell Line J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1291 - 1297. [Abstract] [Full Text]

				G. C. Rossi, L. Leventhal, E. Bolan, and G. W. Pasternak Pharmacological Characterization of Orphanin FQ/Nociceptin and its Fragments J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 858 - 865. [Abstract] [Full Text]

				Y. A. Kolesnikov, Y.-X. Pan, A.-M. Babey, S. Jain, R. Wilson, and G. W. Pasternak Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: Evidence for opposing NO actions on morphine analgesia and tolerance PNAS, July 22, 1997; 94(15): 8220 - 8225. [Abstract] [Full Text] [PDF]

				G. C. Rossi, L. Leventhal, Y.-X. Pan, J. Cole, W. Su, R. J. Bodnar, and G. W. Pasternak Antisense Mapping of MOR-1 in Rats: Distinguishing between Morphine and Morphine-6beta -glucuronide Antinociception J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 109 - 114. [Abstract] [Full Text]